毒性分類
出自台灣有毒中草藥毒性資料庫
（修訂版本間的差異）
| 第4行： | 第4行： | ||
|| | || | ||
<font size=3>級數</font> | <font size=3>級數</font> | ||
| - | | | + | || |
<font size=3>說明</font> | <font size=3>說明</font> | ||
| - | | | + | || |
<font size=3>分數</font> | <font size=3>分數</font> | ||
|- | |- | ||
| + | || | ||
<font size=3>'''Class A'''</font> | <font size=3>'''Class A'''</font> | ||
||<font size=3> Randomized controlled trials have been demonstrated risks or effects to the human bodies.</font> | ||<font size=3> Randomized controlled trials have been demonstrated risks or effects to the human bodies.</font> | ||
在2011年11月3日 (四) 03:01所做的修訂版本
本毒性分級主要參考MICROMEDEX中，RECOMMENDATION, EVIDENCE AND EFFICACY RATINGS的定義來設定資料庫的毒性等級。
|
級數 |
說明 |
分數 |
|
Class A | Randomized controlled trials have been demonstrated risks or effects to the human bodies. | |
|
Class B1 | Drugs which have been investigated via in vivo tests showed potential harmful to human bodies and we need more clinical trials to confirm the toxicity to human. | |
|
Class B2 | Drugs which have been investigated via in vitro tests showed potential harmful to human bodies and further studies should be carried out to confirm it. | |
|
Class C | expert opinion, case reports or case series | |
|
Class D | no evidence |
